Skip to main content

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24

By: Newsfile

Dallas, Texas--(Newsfile Corp. - June 4, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q1 2024.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Prexigebersen Phase 2 underway
  • Numerous drug candidates in the BPTH pipeline
  • $3.5M of funds raised in 2024, giving sufficient liquidity

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7294/211731_figure1_550.jpg

Click image above to view full announcement.


About Stonegate

Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/211731

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.95
+0.00 (0.00%)
AAPL  258.45
+0.00 (0.00%)
AMD  230.23
+0.00 (0.00%)
BAC  51.10
+0.00 (0.00%)
GOOG  252.53
+0.00 (0.00%)
META  733.41
+0.00 (0.00%)
MSFT  520.54
+0.00 (0.00%)
NVDA  180.28
+0.00 (0.00%)
ORCL  272.66
+0.00 (0.00%)
TSLA  438.97
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.